Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapy of Pulmonary Arterial Hypertension (PAH) - Treatment With Sildenafil in Eisenmenger Patients

NCT00586794 is registered in ClinicalTrials.gov with Competence Network for Congenital Heart Defects as lead sponsor.

NCT NCT00586794
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00586794 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapy of Pulmonary Arterial Hypertension (PAH) - Treatment With Sildenafil in Eisenmenger Patients
Lead sponsor
Competence Network for Congenital Heart Defects
Phase
Phase 3
Overall status
Terminated
Start date
December 31, 2007
Completion date
June 30, 2012
Enrollment
24 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary arterial hypertension (pah)